A review of nebulized drug delivery in COPD
Donald P Tashkin Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA Abstract: Current guidelines recommend inhaled pharmacologic therapy as the preferred route of administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics...
Main Author: | Tashkin DP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-10-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/a-review-of-nebulized-drug-delivery-in-copd-peer-reviewed-article-COPD |
Similar Items
-
The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home
by: Deepak Talwar, et al.
Published: (2021-01-01) -
Nebulizer therapy for lung diseases
by: G. L. Ignatova, et al.
Published: (2020-08-01) -
Inhalation properties of water-soluble drug loaded liposomes atomized by nebulizer
by: Shinshu Unida, et al.
Published: (2016-02-01) -
Current possibilities for nebulizer therapy
by: A. A. Zaytsev, et al.
Published: (2019-12-01) -
Magnetic core-shell nanoparticles for drug delivery by nebulization
by: Verma Navin Kumar, et al.
Published: (2013-01-01)